Can Trump Export Zambia’s HIV Success?

Why It Matters

The model promises lower long‑term costs and greater local ownership, but premature export risks undermining hard‑won gains in HIV care across low‑resource settings.

Key Takeaways

• Zambia’s Southern Province shifted PEPFAR funds to direct government financing
• Direct funding cut patient cost from $79 to $44 per year
• Community outreach declined as NGOs lost funding under the new model
• Trump’s aid pause exposed clinic resilience but highlighted funding gaps
• Exporting Zambia’s approach risks leaving vulnerable groups without services

Pulse Analysis

The United States’ President’s Emergency Plan for AIDS Relief (PEPFAR) has been a cornerstone of Africa’s HIV response since 2004, funneling billions into testing, treatment and prevention. In Zambia, a strategic pivot began in 2013 when the CDC started channeling funds directly to provincial governments, culminating in Southern Province’s full transition by 2024. By granting ministries flexibility to hire staff, buy equipment and integrate services into general outpatient departments, the province reduced per‑patient costs dramatically while preserving high treatment adherence rates. This government‑to‑government model is now touted as a template for sustainable health financing.

However, the model’s success hinges on a delicate balance of resources, data systems and community engagement. As direct financing took hold, NGOs that once delivered door‑to‑door testing and medication delivery were sidelined, leading to a sharp decline in outreach to high‑risk groups such as sex workers and men who have sex with men. The Trump administration’s abrupt aid freeze exposed the fragility of this balance, showing that even resilient clinics can falter without dedicated outreach staff. Critics argue that exporting the Zambian blueprint without the accompanying capacity‑building and monitoring frameworks could leave vulnerable populations without essential services.

For policymakers, the lesson is clear: cost‑efficiency must not eclipse equity. Any replication of Zambia’s approach should embed robust data‑driven oversight, protect community‑based networks, and phase funding reductions over a realistic timeline. By coupling direct government financing with sustained technical assistance and safeguards for outreach, donor nations can help low‑income countries build durable HIV programs that survive political shifts while continuing to reach those most at risk.